BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17241179)

  • 1. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
    Mannila MN; Eriksson P; Leander K; Wiman B; de Faire U; Hamsten A; Silveira A
    J Intern Med; 2007 Feb; 261(2):138-47. PubMed ID: 17241179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
    Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
    Gigante B; Vikström M; Meuzelaar LS; Chernogubova E; Silveira A; Hooft FV; Hamsten A; de Faire U
    Thromb Haemost; 2009 May; 101(5):943-53. PubMed ID: 19404549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study.
    Cheung EY; Bos MJ; Leebeek FW; Koudstaal PJ; Hofman A; de Maat MP; Breteler MM
    Thromb Haemost; 2008 Aug; 100(2):308-13. PubMed ID: 18690352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
    Mannila MN; Lovely RS; Kazmierczak SC; Eriksson P; Samnegård A; Farrell DH; Hamsten A; Silveira A
    J Thromb Haemost; 2007 Apr; 5(4):766-73. PubMed ID: 17263791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction.
    Mannila MN; Eriksson P; Lundman P; Samnegård A; Boquist S; Ericsson CG; Tornvall P; Hamsten A; Silveira A
    Thromb Haemost; 2005 Mar; 93(3):570-7. PubMed ID: 15735812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: results from the MONICA/KORA study.
    Kolz M; Baumert J; Gohlke H; Grallert H; Döring A; Peters A; Wichmann HE; Koenig W; Illig T
    Thromb Haemost; 2009 Feb; 101(2):317-24. PubMed ID: 19190816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the fibrinogen-alpha and fibrinogen-gamma genes in relation to arterial stiffness: the Rotterdam Study.
    Sie MP; Isaacs A; de Maat MP; Mattace-Raso FU; Uitterlinden AG; Kardys I; Hofman A; Hoeks AP; Reneman RS; van Duijn CM; Witteman JC
    J Hypertens; 2009 Jul; 27(7):1392-8. PubMed ID: 19412134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study.
    Kardys I; Uitterlinden AG; Hofman A; Witteman JC; de Maat MP
    Thromb Haemost; 2007 Feb; 97(2):288-95. PubMed ID: 17264959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fibrinogen beta-chain gene variations on risk of myocardial infarction in a Chinese Han population.
    Lu XF; Yu HJ; Zhou XY; Wang LY; Huang JF; Gu DF
    Chin Med J (Engl); 2008 Aug; 121(16):1549-53. PubMed ID: 18982866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
    Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
    Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen genes and myocardial infarction: a haplotype analysis.
    Koch W; Hoppmann P; Biele J; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):758-63. PubMed ID: 18202324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
    Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
    Kathiresan S; Yang Q; Larson MG; Camargo AL; Tofler GH; Hirschhorn JN; Gabriel SB; O'Donnell CJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1405-12. PubMed ID: 16614319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
    Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
    Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
    Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
    Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study.
    Welsh P; Woodward M; Rumley A; Lowe G
    Cytokine; 2009 Aug; 47(2):143-7. PubMed ID: 19581111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study.
    Tobin MD; Braund PS; Burton PR; Thompson JR; Steeds R; Channer K; Cheng S; Lindpaintner K; Samani NJ
    Eur Heart J; 2004 Mar; 25(6):459-67. PubMed ID: 15039125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.